# QA Team AI Automation — Strategy Brief

**Author:** _[name]_
**Date:** _[date]_
**Status:** Draft v0.1 — for leadership review
**Decision required by:** _[date]_

---

## 1. Executive Summary

_Write last. 3–5 sentences covering: (1) the problem in one line, (2) proposed direction in one line, (3) expected value with one quantified outcome, (4) the explicit ask._

_The proposed direction should not assume the solution. If the evidence does not support an AI-shaped answer, say so — the brief is a decision document, not a sales pitch._

> Example shape (illustrative only — do not anchor your problem statement to this one): "QA verification is currently a 5-day bottleneck on every release, blocking ~30% of sprint goals. We propose evaluating AI-assisted approaches across test authoring, data management, run orchestration, and result verification, alongside a non-AI baseline. Expected outcome: reduce verification cycle from 5 days to <1 day within two quarters, against a measurable baseline. We are asking for [X] funding and a [Y]-week pilot approval."

---

## 2. Problem Statement

_One paragraph. Specific, measurable, solution-agnostic. State the bottleneck as it exists today and its business impact. Avoid naming tools or AI capabilities here._

---

## 3. Current State

### 3a. Process Journey

_Step-by-step flow from initiation to release. Insert diagram if available._

| #   | Step                      | Owner | Avg. Duration | Tooling |
| --- | ------------------------- | ----- | ------------- | ------- |
| 1   | Test authoring            |       |               |         |
| 2   | Test data preparation     |       |               |         |
| 3   | Test run orchestration    |       |               |         |
| 4   | Result verification       |       |               |         |
| 5   | Defect triage / reporting |       |               |         |

### 3b. Personas Involved

_This table describes **process roles** (who participates in the QA flow and where), not org structure or headcount. Org structure belongs in §6 Dependencies if relevant._

| Persona         | Role in Process | Primary Pain |
| --------------- | --------------- | ------------ |
| QA Engineer     |                 |              |
| Developer       |                 |              |
| Release Manager |                 |              |
| Product Owner   |                 |              |
| _[other]_       |                 |              |

### 3c. Pain Points

_Quantify wherever possible. Unquantified pain is hard to defend in review._

| Pain Point | Affected Persona | Quantified Impact | Frequency |
| ---------- | ---------------- | ----------------- | --------- |
|            |                  |                   |           |
|            |                  |                   |           |

### 3d. Baseline Metrics

_The numbers future state will be measured against. Every row must declare its **Confidence**:_
- _**Tracked** — instrumented, source of truth exists. Cite source._
- _**Estimated (n=X)** — clustered from X interviews. Cite the cluster (range, median) in Notes._
- _**TBD — needs instrumentation** — neither tracked nor reliably estimable. Do not invent a number._

_Estimated values are acceptable as baselines for v0.1 but must be re-validated before any post-pilot comparison claim. A target cannot be set against a TBD baseline._

| Metric                                | Current Value | Confidence | Source | Notes |
| ------------------------------------- | ------------- | ---------- | ------ | ----- |
| Avg. test authoring time per scenario |               |            |        |       |
| Avg. verification time per run        |               |            |        |       |
| Verification hours / sprint           |               |            |        |       |
| Defect escape rate                    |               |            |        |       |
| Hotfix rate per release               |               |            |        |       |
| Release cycle time                    |               |            |        |       |
| QA-blocked release %                  |               |            |        |       |
| Flake rate / re-run rate              |               |            |        |       |

---

## 4. Future State

### 4a. Target State Description

_What "good" looks like once this is done. Describe the operating model, not the implementation. Should be testable against the baseline metrics in 3d._

### 4b. AI Integration Points

_Map AI capabilities to specific journey steps. Be honest about maturity — distinguish established capabilities from emerging ones._

| Journey Step         | AI Capability Applied                          | Capability Maturity                   | Expected Effect |
| -------------------- | ---------------------------------------------- | ------------------------------------- | --------------- |
| Test authoring       | _e.g. LLM-assisted test generation from specs_ | Established / Emerging / Experimental |                 |
| Test data management |                                                |                                       |                 |
| Run orchestration    |                                                |                                       |                 |
| Result verification  |                                                |                                       |                 |
| Defect triage        |                                                |                                       |                 |

### 4c. Updated Process Journey

_Mirror the table in 3a, post-implementation. Bold or annotate the changed steps._

| #   | Step | Owner | Avg. Duration | Tooling | Δ vs. Current |
| --- | ---- | ----- | ------------- | ------- | ------------- |
| 1   |      |       |               |         |               |

---

## 5. Expected Value

_Every quantitative line must reference a metric in 3d. Every qualitative line must cite either a 3d metric (as a leading indicator) or a specific 3c pain point. Unsupported claims belong nowhere in this section._

### Quantitative

| Outcome | Baseline (from 3d) | Target | Time to Achieve |
| ------- | ------------------ | ------ | --------------- |
|         |                    |        |                 |

### Qualitative

_Each entry must point to its evidence (3c pain ID or 3d metric as leading indicator). Drop any entry without evidence — leadership will, anyway._

| Qualitative Outcome | Evidence Source (3c pain or 3d metric) | Why this matters |
| ------------------- | -------------------------------------- | ---------------- |
| _e.g. Developer experience_ | _3c pain: "devs context-switch ~3x while waiting on QA"_ |  |
| _e.g. Release confidence_   |                                        |  |
| _e.g. Capacity reallocation_ |                                       |  |
| _e.g. Hiring leverage — only if 3c pain on attrition or unfilled headcount exists_ |  |  |

---

## 6. Assumptions, Risks, Dependencies

### Assumptions

_What must be true for this plan to succeed. If any are violated, the plan needs revision._

- _[e.g. Verification model accuracy reaches ≥X% on representative test runs]_
- _[e.g. Existing test artifacts are sufficient training/grounding data]_
- _[e.g. Vendor pricing remains within projected range]_

### Risks

_Cover both **adoption risks** (current-state friction blocking the change) and **proposed-change risks** (failure modes of the proposed solution itself: hallucinated tests, false confidence, maintenance burden, governance overhead, opportunity cost of pursuing this over alternatives)._

| Risk | Category                                                  | Likelihood | Impact | Mitigation |
| ---- | --------------------------------------------------------- | ---------- | ------ | ---------- |
|      | Technical / Organizational / Vendor / Compliance / Adoption | L/M/H    | L/M/H  |            |

### Stop Conditions

_Pre-committed criteria that would halt or reverse the initiative. If you can't write these, the proposal isn't ready for funding._

| Trigger | Threshold | Action |
| ------- | --------- | ------ |
| _e.g. Pilot defect-escape rate exceeds baseline_ | _>baseline for 2 consecutive releases_ | _Pause expansion, root-cause review_ |
| _e.g. Verification model accuracy below acceptable floor_ | _<X% on representative sample_ | _Roll back; revert to manual_ |
| _e.g. Vendor cost runaway_ | _>X% above projection_ | _Re-scope or terminate_ |

### Security & Data Governance

_AI tooling that reads proprietary code, test data, or production-derived fixtures will face InfoSec, legal, and compliance review. Surface these constraints **here**, not after a vendor is chosen._

- **Data classification of test artifacts:** _[public / internal / confidential / regulated — and which apply]_
- **PII / regulated data exposure in test data:** _[present / absent / requires masking]_
- **Vendor data-handling requirements:** _[where data goes, retention, training-on-customer-data posture]_
- **Required sign-offs:** _[InfoSec, Legal, Privacy, Platform/Infra — name the function, not the person]_
- **Existing approved-tooling envelope:** _[is there a vendor list / model list this must fit within?]_

### Dependencies

| Dependency | Owner | Required By |
| ---------- | ----- | ----------- |
|            |       |             |

---

## 7. Proposed Approach

_High-level phasing only — not implementation detail. Phase 1 should be highest ROI / lowest risk and produce a measurable signal that informs Phase 2._

| Phase      | Scope | Duration | Success Criteria |
| ---------- | ----- | -------- | ---------------- |
| 1 — Pilot  |       |          |                  |
| 2 — Expand |       |          |                  |
| 3 — Scale  |       |          |                  |

### Build vs. Buy

_Leadership will ask. Have an answer._

| Option | Fit for our context | Cost shape | Time to value | Lock-in / risk |
| ------ | ------------------- | ---------- | ------------- | -------------- |
| Buy (vendor) |               |            |               |                |
| Build (in-house) |           |            |               |                |
| Hybrid |                     |            |               |                |

**Recommended stance:** _[buy / build / hybrid] because [reason tied to 3c pain or 6 risk]._

### Opportunity Cost — the "Do Nothing" baseline

_What happens to the metrics in 3d over the next 2–4 quarters if we do not approve this? What other QA investments are we forgoing if we approve it? An initiative is worth funding only if it beats both the do-nothing trajectory and the next-best alternative use of the same capacity._

- **Do nothing — projected 3d trajectory:** _[which metrics worsen, by how much, over what window]_
- **Next-best alternative use of this capacity:** _[e.g. instrumentation work, hiring, tooling refresh] — and why this proposal beats it_

---

## 8. The Ask

_Explicit. Vague asks produce vague responses._

_Sourcing note: this section is filled from sponsor/leadership context the author already has, **not** invented from interviews. If you don't know a decision-maker or budget envelope, write "TBD — needs sponsor conversation" rather than guessing. Required sign-offs surfaced in §6 Security & Data Governance must appear here as decision-makers._

- **Funding:** _[amount and category]_
- **Headcount / time allocation:** _[FTEs, hours, duration]_
- **Pilot scope approval:** _[what teams, what surface area]_
- **Decision needed by:** _[date]_
- **Decision-maker(s):** _[names / roles, including required sign-offs from §6]_

---

## Appendix (optional)

- A. Glossary of AI capability terms
- B. Vendor / tooling landscape scan
- C. Detailed metric definitions
- D. Reference architectures / vendor landscape considered